March 30 (Reuters) - Fennec Pharmaceuticals Inc FRX.TO :
* Fennec provides corporate update and announces fiscal year ended December 31, 2016 financial results
* Fennec Pharmaceuticals Inc qtrly loss per share $0.08 Source text for Eikon: ID:nCCN8Rg68j Further company coverage: FRX.TO